Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ScienceCloud by Accelrys Transforms Externalized Drug Discovery

Published: Tuesday, February 11, 2014
Last Updated: Tuesday, February 11, 2014
Bookmark and Share
New cloud solution for externalized life science research and development redefines collaboration and creativity

Accelrys, Inc., a leading provider of scientific innovation lifecycle management software, has announced the launch of ScienceCloud, a new SaaS-based information management and collaboration workspace. ScienceCloud advances collaborative drug discovery with a new generation of integrated applications built on a scalable, cloud-based scientific platform. With no software to manage and no hardware to maintain, ScienceCloud improves operational excellence in globally networked research, significantly reducing IT cost and effort.

“With externalized R&D collaboration on the rise in the life sciences, organizations are turning to the cloud as a secure, scalable, elastic environment for effectively connecting virtual teams and sharing data, information and knowledge,” said Alan S. Louie, Ph.D., research director, IDC Health Insights. “Improved business agility, reduced TCO and anywhere-anytime information access make the cloud an excellent venue for rolling out a successful collaboration strategy.”

As the next step in Accelrys’ externalized collaboration initiative, ScienceCloud takes secure, real-time transfer of project data within geographically-dispersed life science research networks to a new level. ScienceCloud provides project-centered IP storage in a secure information warehouse and enforces sponsor business rules on results posted by network partners.  ScienceCloud enhances the virtual workspace with new mobile applications and tools, allowing project teams to leverage social communication for building and sharing project information. The result is a more holistic collaboration strategy for partnering pharmaceutical and biotechnology companies, contract research organizations (CROs) and academic research teams.

“Today a significant amount of discovery work is done through partner alliances,” said Matt Hahn, Ph.D., senior vice president and chief technology officer at Accelrys. “Because of this new business model, life science partner networks need better ways to connect and collaborate than email, e-rooms and repurposed legacy systems. ScienceCloud is a flexible and robust workspace where virtual project teams can securely share the data and apps they need to drive successful outcomes in a fast-changing global and mobile research landscape.”

ScienceCloud provides applications to upload, process, store, search and analyze structured and unstructured scientific records critical for drug discovery projects including biology, chemistry, analytical, safety and pharmacokinetics data. With ScienceCloud, scientists can rapidly access research data including experiments, chemical structures, assays and other test results and are able to make informed decisions based on the most complete and current information available. Research managers gain continuous visibility into projects and the ability to understand the latest results across all organizations involved. As collaboration networks evolve, it is easy for sponsoring organizations to quickly spin up and spin down partner engagements with the data they provide securely partitioned in the system.

ScienceCloud leverages an open ecosystem of web and mobile-accessible application capabilities initially including:

• Collaborative Project Management: ScienceCloud provides secure project management and the ability to share project information (whether structured data or documents) using a unique social networking approach to scientific collaboration.
• Experiment and IP Capture:  Accelrys Notebook, a flexible, multi-disciplinary, low-cost-of-ownership electronic lab notebook empowers sponsor organizations and network partners to capture and share experimental methods.
• Custom Business Rules Extension: Accelrys Pipeline Pilot, a scientific workflow authoring application, facilitates the creation and management of scientific services, implements standard business rules and enables integration between ScienceCloud and on-premises systems, allowing data to flow from one environment to the other.
• Mobile Device Enablement: A mobile iOS application lets scientists access the ScienceCloud, execute ScienceCloud tasks and share results with colleagues. An associated Accelrys Pipeline Pilot Mobile Collection allows developers to build scientific protocols which can be deployed to mobile devices, leveraging mobile capabilities such as sound and image capture, location services, speech-to-text, etc.
• Publishing and Sharing Services: TheScienceCloud Exchange is an open portal where scientists can publish and share Accelrys Pipeline Pilot protocols (e.g., reports created from ScienceCloud data), enhancing broad dissemination of essential research tools within the ScienceCloud community. 

Accelrys is uniquely qualified in the SaaS-based research informatics market with a proven track record of over ten years delivering successful cloud offerings including hosted content in Accelrys DiscoveryGate, Accelrys Notebook Cloud and Accelrys HEOS, the industry's first CRO partner collaboration platform. Accelrys' depth of experience in scientific research; long-term vision of the solutions needed to address today’s collaboration challenges; and strong track record of partnering with customers make ScienceCloud the ideal solution for the new frontier of externalized collaborative research.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ALMA Welcomes Accelrys as a Premium Sponsor
Association of Lab Managers (ALMA) now supported by leading lab software provider Accelrys
Friday, April 04, 2014
Dassault Systèmes and Accelrys to Join Forces
Delivering Scientific Innovation in the Age of Experience
Friday, January 31, 2014
Accelrys Acquires QUMAS
The acquisition extends Accelrys’ informatics portfolio with the addition of mission-critical, end-to-end document and process management compliance solutions.
Tuesday, December 10, 2013
Accelrys Advances Biology Innovation with New Release of Assay and Study Management Product Suite
Accelrys BioRails 4.5 and Accelrys Morphit 3.0 accelerate assay pipelines, improve cascade management and enhance collaborative decision-making in discovery biology.
Tuesday, November 19, 2013
Accelrys Receives Highest Rating in Gartner's Latest Laboratory Informatics System Report
Accelrys was the only vendor to achieve the highest possible rating in all five categories of new product development (NPD)
Friday, October 11, 2013
Cambridge Isotope Laboratories Selects Accelrys Lab Automation Software
Cambridge Isotope Laboratories, Inc. is deploying the Accelrys Laboratory Execution System (LES) and three applications within the Accelrys Laboratory Information Management System.
Tuesday, September 10, 2013
Accelrys Acquires Environmental Health and Safety Leader ChemSW
Chemical inventory management solutions improve compliance and sustainability impact of Accelrys’ Scientific Innovation Lifecycle Management portfolio
Wednesday, September 04, 2013
Cambridge Isotope Laboratories Selects Accelrys Lab Automation Software
Enterprise implementation follows successful pilot that achieved a 78 percent reduction in data review times and a 40 percent overall improvement in lab processing time
Sunday, September 01, 2013
The Evolution of the Integrated Platform: Accelrys' One-Two Punch
A look at how Accelrys is delivering an integrated platform of enterprise laboratory solutions.
Sunday, June 02, 2013
Accelrys and eMolecules Collaborate to Enhance Accelrys Available Chemicals Directory
Validated and curated in-stock compounds from eMolecules now accessible through Accelrys ACD
Saturday, April 06, 2013
Accelrys' Electronic Laboratory Notebooks Recognized in Gartner's Enterprise Category
Accelrys' electronic laboratory notebooks (ELN) as "very high" or "high" in each scientific and functional domain in a recent report by Gartner, Inc.
Sunday, March 03, 2013
Accelrys® ELN Delivers Seamless Integration with the Reaxys® Workflow Solution
New chemistry information management possibilities for research scientists arising from Accelrys' cooperation with Elsevier.
Sunday, March 03, 2013
Accelrys, Inc. Acquires Vialis AG
Accelrys Strengthens Leadership Position in Laboratory Informatics Market
Sunday, February 10, 2013
Accelrys Acquires Systems Integrator Vialis
Accelrys has acquired Vialis AG to solidify its market leadership in the laboratory informatics space
Sunday, January 20, 2013
German Cancer Research Center Selects Contur ELN from Accelrys
The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) has licensed the server-based, on-premises version of Accelrys' Contur Electronic Lab Notebook (ELN).
Friday, December 28, 2012
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!